Asia Beat: Almighty yen not all bad news for Japanese pharma
This article was originally published in Scrip
Executive Summary
Spells of unusually cool weather may have provided some respite from the typically hot and humid Japanese summer, but there has been no let up in the seemingly unstoppable rise of the yen to sweltering levels.
You may also be interested in...
Quick Listen: Scrip’s Five Must-Know Things
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
Catchup Capsule: Key APAC Insights You Need To Read
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Catchup Capsule: Key APAC Insights You Need To Read
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Need a specific report? 1000+ reports available
Buy Reports